NCT01674036View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy Men

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Healthy Volunteer
Interventions
DRUG

Genz-682452

Capsules for oral administration.

DRUG

Placebo

Placebo to Genz-682452

Trial Locations (1)

Unknown

Austin

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT01674036 - Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy Men | Biotech Hunter | Biotech Hunter